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Background: The aim of this study was to compare the efficacy of spectral-domain optical 
coherence tomography (SD-OCT) and fluorescein angiography (FA) in the guidance of macular 
laser photocoagulation for diabetic macular edema.
Methods: This was a prospective interventional clinical comparative pilot study. Forty eyes 
from 24 consecutive patients with diabetic macular edema were allocated to receive laser pho-
tocoagulation guided by SD-OCT or FA. Best-corrected visual acuity (BCVA), central macular 
thickness, and retinal volume were assessed at baseline and two months after treatment.
Results: Subjects treated using FA-guided laser improved BCVA from the logarithm of the 
minimum angle of resolution (logMAR) 0.52 ± 0.2 to 0.37 ± 0.2 (P , 0.001), and decreased 
mean central macular thickness from 397.25 ± 139.1 to 333.50 ± 105.7 µm (P , 0.001) and 
retinal volume from 12.61 ± 1.6 to 10.94 ± 1.4 mm3 (P , 0.001). Subjects treated using   SD-OCT 
guided laser had improved BCVA from 0.48 ± 0.2 to 0.33 ± 0.2 logMAR (P , 0.001), and 
decreased mean central macular thickness from 425.90 ± 149.6 to 353.4 ± 140 µm (P , 0.001) 
and retinal volume from 12.38 ± 2.1 to 11.53 ± 1.1 mm3 (P , 0.001). No significant differences 
between the groups were found in two-month BCVA (P = 0.505), two-month central macular 
thickness (P = 0.660), or two-month retinal volume (P = 0.582).
Conclusion: The short-term results of this pilot study suggest that SD-OCT is a safe and 
  effective technique and could be considered as a valid alternative to FA in the guidance of 
macular laser photocoagulation treatment for diabetic macular edema.
Keywords: spectral-domain optical coherence tomography, fluorescein angiography, macular 
laser photocoagulation, diabetic macular edema
Introduction
Macular laser photocoagulation is the gold standard therapy for diabetic macular edema, 
being the only treatment with the first level of evidence.1 It has been optimized by 
directing the laser spots to the leaking areas shown on fluorescein angiography (FA).2 
However, FA is associated with severe potential risks. Gastrointestinal disturbances, 
mainly nausea and vomiting, are the most frequent adverse reactions during FA, which 
appear in up to 10% of these procedures.3 Cases of pulmonary edema, myocardial 
infarction, or anaphylactic shock have also been reported during FA.4–6 In addition to 
these risks, FA may be a time-consuming procedure when peripheral veins are difficult 
to cannulate, and this enhances patient discomfort.
On the other hand, using spectral-domain optical coherence tomography (SD-OCT), 
retinal images with axial resolutions of about 5 µm can be obtained and displayed Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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as a three-dimensional color-coded map superimposed 
and aligned on macular retinography. Vascular leakage in 
diabetic retinopathy is the source of increased retinal thick-
ness and subsequent macular edema.7 Whereas FA offers 
information about the leaking areas within the macular area 
responsible for thickening of the retina, SD-OCT shows those 
thickened areas in the map resulting from leakage of vessels. 
We hypothesized that effective macular laser photocoagu-
lation can be applied, obtaining indirect information of the 
points where macular laser treatment should be precisely 
placed utilizing SD-OCT, without exposing the patient to 
the potential risks of FA and with an image acquisition pro-
cess that takes a few seconds. The aim of this study was to 
compare the efficacy of SD-OCT and FA in the guidance of 
macular laser photocoagulation for the treatment of diabetic 
macular edema.
Materials and methods
This was a prospective, interventional, comparative, pilot 
clinical study that included 40 eyes from 24 consecutive 
patients with diabetic macular edema. The diagnosis was 
  sustained by fundus examination, FA, and SD-OCT   (HD-OCT 
Cirrus® and Carl Zeiss Meditec®, Dublin, CA). Inclusion cri-
teria were: clinically significant diabetic macular edema as 
defined by the Early Treatment Diabetic   Retinopathy Study 
(ETDRS);8 significant elevation of the retina topographi-
cally mapped in a color code, with red (400–500 µm) and 
white (.500 µm) indicating a definitely thickened area as 
measured by OCT; any loss of visual acuity; and macular 
vessel leakage on FA. Exclusion criteria were: proliferative 
diabetic retinopathy; severe ischemia which made reasonable 
the application of panretinal   photocoagulation; intravitreal 
injection of vascular endothelial growth factor A inhibi-
tors at any time; intravitreal or sub-Tenon’s corticosteroid 
treatment within the previous six months; laser treatments 
within the previous three months; angiographic evidence 
of macular ischemia; presence of retinal disease other than 
diabetic retinopathy; evidence of uncontrolled diabetes 
  (glycosylated hemoglobin . 8%), systemic arterial hyper-
tension (systolic . 150 mmHg, diastolic . 100 mmHg); 
smoking; and insufficient mydriasis or unclear media limiting 
the possibility of obtaining accurate retinograms. Approval 
was obtained from the institutional ethics committee, and 
informed consent was obtained for the study. In addition, this 
study was performed in accordance with the ethical standards 
laid down in the Declaration of Helsinki.
As soon as the diagnosis was confirmed by OCT and 
FA, all patients were treated with macular photocoagulation. 
Eyes were selected to receive laser with argon following 
the ETDRS guidelines guided by FA or OCT in a 1:1 ratio. 
Whereas in FA-guided photocoagulation the laser spots were 
placed within the leaking areas showed in the angiogram 
(Figure 1), the laser spots in OCT-guided photocoagulation 
were placed within the thickened areas provided by the retinal 
thickness map obtained with the macular cube 512 × 128 
acquisition protocol for the HD-OCT Cirrus® (Figure 2). 
All laser treatments were done by the same clinician (RGP), 
who was provided only OCT or FA (depending on the group 
studied) in order to guide the therapy.
All patients had a follow-up visit at two months. The 
follow-up examination included best-corrected visual acuity 
(BCVA) as measured by ETDRS charts (converted to the 
logarithm of the minimum angle of resolution [logMAR], 
and Snellen equivalent) and measurement of central   macular 
thickness and retinal volume by SD-OCT. All patients 
attended the follow-up examination during the study. The 
main outcome parameters were BCVA, macular thickness, 
and retinal volume, as measured by SD-OCT.
Statistical analysis was performed using commercially 
available software (SPSS for Windows, version 13.0, SPSS 
Inc, Chicago, IL). The data were confirmed to distribute 
normally and therefore are presented as the mean ± standard 
deviation. To compare the measurements taken at baseline 
with those obtained at follow-up, the parametric Student’s 
t-test for paired samples was performed. The level of signifi-
cance was 0.05 (two-sided) for all statistical tests.
Results
Baseline patient characteristics
The mean age of the study population was 62.17 ± 9.0 years 
(15 males and nine females). Mean BCVA was 0.50 ± 0.2 
logMAR (0.36 ± 0.16 Snellen acuity). Mean central macular 
thickness was 425.90 ± 149.6 µm, and mean retinal volume 
was 12.00 ± 1.8 mm3.
Figure  1  Example  of  fluorescein  angiography  guidance  of  macular  laser 
photocoagulation  (A)  showing  the  leaking  area  of  the  macula  (surrounded  by 
arrowheads). The equivalent color fundus photograph (B) is used to show the laser 
spot location mapping (blue asterisks).Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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FA-guided macular  
photocoagulation group
Twenty eyes from 12 patients were assigned to this group. 
Mean age was 61.6 ± 7.9 (seven males and five females), mean 
BCVA was 0.52 ± 0.2 logMAR (0.35 ± 0.2 Snellen   acuity), 
mean central macular thickness was 397.25 ± 139.1 µm, 
and mean retinal volume was 12.61 ± 1.6 mm3. Two 
months after the initial laser treatment, mean BCVA was 
0.37 ± 0.2   logMAR (0.47 ± 0.2 Snellen acuity), mean cen-
tral macular thickness was 333.50 ± 105.7 µm, and mean 
retinal volume was 10.94 ± 1.4 mm3. Statistically significant 
(P , 0.001) differences were found between pre- and post-
laser treatment measurements of retinal volume, BCVA, and 
central macular thickness. Baseline characteristics and post-
laser outcomes in the FA-guided macular photocoagulation 
group are   summarized in Table 1.
OCT-guided macular  
photocoagulation group
Twenty eyes from 12 patients were assigned to this group. 
Mean age was 62.8 ± 10.3 (eight males and four females), mean 
BCVA was 0.48 ± 0.2 logMAR (0.37 ± 0.2 Snellen   acuity), 
mean central macular thickness was 425.90 ± 149.6 µm, and 
mean retinal volume measured 12.38 ± 2.1 mm3. Two months 
after initial laser treatment, mean BCVA was 0.33 ± 0.2 
logMAR (0.45 ± 0.2 Snellen acuity), mean central macular 
thickness was 353.4 ± 140 µm, and mean retinal volume 
was 11.53 ± 1.1 mm3. Statistically significant (P , 0.001) 
differences were found between pre- and post-laser treatment 
measures of retinal volume, BCVA, and central macular 
thickness. Baseline characteristics and post-laser outcomes 
in the OCT-guided macular photocoagulation group are 
summarized in Table 2.
Table 1 Baseline and endpoint characteristics of patients assigned to macular laser photocoagulation guided by fluorescein angiography 
findings
Patient no Gender Age Eye no BCVA (logMAR) CMT (μm) RV(mm3)
Baseline Endpoint Baseline Endpoint Baseline Endpoint
1 F 62 1 0.4 0.4 301 275 10.9 10.1
2 F 67 2
3
0.2
0.3
0.2
0.3
334
424
344
396
11.0
10.6
10.9
10.5
3 F 56 4 0.2 0.1 244 213 8.6 8.4
4 F 51 5
6
0.7
0.5
0.4
0.5
170
195
164
180
11.2
11.7
9.6
11.9
5 M 62 7
8
0.5
0.5
0.4
0.4
272
387
244
321
10.6
11.3
10.6
10.6
6 M 54 9 0.7 0.5 439 298 14.4 13.1
7 M 71 10
11
0.8
0.4
0.5
0.2
740
567
589
344
13.6
12.8
11.9
10.9
8 F 72 12
13
0.3
0.5
0.1
0.5
353
422
290
413
11.6
11.3
10.7
10.6
9 M 69 14
15
0.5
0.5
0.3
0.3
375
396
327
316
10.6
10.5
10.3
10.1
10 M 48 16
17
0.4
1
0.4
0.7
472
579
493
369
12.8
14.1
12.8
13.4
11 M 66 18
19
0.4
0.5
0.2
0.2
357
352
297
303
10.7
9.8
9.5
9.6
12 M 61 20 1 0.7 566 494 14.1 13.2
Abbreviations: FA, fluorescein angiography; F, female; M, male; BCVA, best-corrected visual acuity; CMT, central macular thickness; RV, retinal volume.
Figure 2 Example of spectral-domain optical coherence tomography (SD-OCT) 
guidance  of  macular  laser  photocoagulation.  Retinal  thickness  color  map  (A) 
obtained by SD-OCT software; a fundus photograph (B) is also registered; finally, a 
composition of the map superimposed and aligned on the fundus image is provided 
automatically by sD-OCT (C). The equivalent color fundus photograph (D) is used 
to show the laser spot location mapping (blue asterisks) avoiding the foveal area.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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intergroup comparison
No statistically significant differences were found between 
the two study groups in terms of baseline characteristics 
(age P = 0.774, BCVA P = 0.647, central macular thick-
ness P = 0.552, and retinal volume P = 0.151). In the com-
parison of BCVA and OCT outcomes between the group 
of patients treated with FA-guided and those treated with 
OCT-guided macular laser photocoagulation, there were no 
significant differences at two months for BCVA (P = 0.505), 
central macular thickness (P = 0.660), or retinal volume   
(P = 0.582).
Discussion
Our results suggest that macular photocoagulation for 
  diabetic macular edema can be guided by the retinal thick-
ness map obtained with SD-OCT. No statistically significant 
  differences were observed in terms of BCVA improve-
ment or decrease in central macular thickness between 
patients treated following FA macular leakage and those 
treated only with the SD-OCT thickness map guide. To 
our knowledge, this is the first study to compare SD-OCT 
and FA as therapeutic approaches for diabetic macular   
edema.
Since OCT technology was first described, it has 
become a widely used imaging acquisition procedure in 
  ophthalmology.9 With the former generation time-domain 
systems (TD-OCT), two-dimensional cross-sectional reti-
nal images with axial resolutions of 10 µm can be obtained 
and a color-coded macular thickness map configured by 
the software. Sensitivity of detecting clinically significant 
diabetic macular edema by measuring retinal thickness 
with   TD-OCT is 89% and the specificity is 86%–96%.10,11 
Currently,   SD-OCT technology improves the resolution to 
about 5 µm and acquires depth information by analyzing 
the interference pattern in the spectrum of mixed reflected 
lights.
The correlation between SD-OCT findings and 
FA patterns in diabetic macular edema has been the 
subject of several studies looking for diagnostic and 
  histopathological clues.12–15 Thus, extrafoveal outer retinal 
cystic changes   correspond to mild retinal edema on FA when 
only the outer plexiform layer is affected, and to more pro-
nounced forms of edema when also the outer nuclear layer is 
affected. The severity of the extrafoveal inner retinal cystic 
changes showed a positive correlation with the severity of 
leakage on FA, and extrafoveal loss of retinal layers corre-
sponded with capillary nonperfusion on FA.15 In addition, 
vitreomacular interface characteristics are clearly shown in 
SD-OCT, whereas FA gives poor information about these 
abnormalities.
Table 2 Baseline and endpoint characteristics of the patients assigned to macular laser photocoagulation guided by SD-OCT retinal 
thickness map
Patient no Gender Age Eye no BCVA (logMAR) CMT (μm) RV (mm3)
Baseline Endpoint Baseline Endpoint Baseline Endpoint
13 M 63 21 0.8 0.5 428 338 13.9 12.3
14 F 64 22
23
1
0.8
0.8
0.5
875
647
562
319
17.9
14.9
14.0
12.3
15 M 55 24 0.4 0.4 358 332 8.8 8.6
16 M 52 25
26
0.7
0.4
0.3
0.2
519
456
341
207
13.7
12.8
12.2
11.1
17 M 74 27
28
0.3
0.5
0.2
0.5
276
423
242
311
10.3
12.9
9.6
11.5
18 M 65 29
30
0.5
0.4
0.4
0.3
310
454
288
326
13.7
11.3
12.8
10.9
19 F 57 31
32
0.3
0.3
0.2
0.2
324
355
256
294
11.8
11.7
10.9
10.6
20 M 41 33
34
0.2
0.3
0.1
0.3
278
296
219
234
12.1
10.4
11.7
9.9
21 F 76 35
36
0.4
0.2
0.2
0.1
394
302
313
287
10.5
10.2
10.1
10.1
22 M 68 37
38
0.7
0.7
0.4
0.5
572
563
345
538
14.5
13.2
11.5
12.5
23 F 63 39 0.3 0.1 335 315 11.1 9.4
24 M 75 40 0.4 0.3 346 331 11.9 11.0
Abbreviations: SD OCT, spectral-domain optical coherence tomography; F, female; M, male; BCVA, best-corrected visual acuity; CMT, central macular thickness;   
rV, retinal volume.Clinical Ophthalmology
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Retinal ischemia in diabetic maculopathy is an important 
predictor of poor functional outcome. Clinical suspicion for 
macular ischemia may be established when visual acuity is 
poorer than expected by fundus examination and SD-OCT 
images. Fluorescein angiography is the gold standard tech-
nique to diagnose nonperfusion. However, loss of retinal 
layers on SD-OCT has been characterized as a specific pre-
dictive sign of capillary nonperfusion and severe   ischemia. 
Therefore, in such cases, structural changes, as well as 
macular perfusion status and central retinal thickness, should 
be analyzed. Nowadays SD-OCT cannot replace FA for this 
purpose.
Limitations of our pilot study include the fact that it was 
nonrandomized, and it had a limited number of patients and a 
relatively short follow-up. However, the results were promis-
ing and suggest the need for further investigation.
The short-term results of this pilot study suggest that 
SD-OCT is a safe and effective technique and could be 
considered as a valid alternative to FA in the guidance 
of macular laser photocoagulation treatment for diabetic 
macular edema. Although macular perfusion status does 
not need to be routinely assessed when evaluating diabetic 
patients, we suggest that a retinal thickness map should 
be used to plan laser spot location during the first macu-
lar photocoagulation treatment and even more in further 
retreatments, making use of a noninvasive and rapid 
technique that provides the same topographic information 
as FA. Evaluation of   SD-OCT-guided laser photocoagula-
tion in a multicenter randomized controlled clinical trial 
is warranted.
Disclosure
The authors declare no financial or proprietary interest in any 
of the products or techniques mentioned in this article.
References
  1.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic 
Retinopathy Study Report Number 1. Arch Ophthalmol 1985;103: 
1796–1806.
  2.  Early Treatment Diabetic Retinopathy Study Research Group. Focal 
photocoagulation treatment of diabetic macular edema.   Relationship 
of treatment effect to fluorescein angiographic and other retinal 
  characteristics at baseline: ETDRS Report Number 19. Arch Ophthalmol 
1995;113:1144–1155.
  3.  Ellis PP, Schoenberger M, Rendi MA. Antihistamines as prophy-
laxis against side reactions to intravenous fluorescein. Trans Am 
Ophthalmol Soc. 1980;78:190–205.
  4.  Hess JB, Pacurariu RI. Acute pulmonary edema following intravenous 
fluorescein angiography. Am J Ophthalmol. 1976;82:567–570.
  5.  Deglin SM, Deglin EA, Chung EK. Acute myocardial infarction 
  following fluorescein angiography. Heart Lung. 1977;6:505–509.
  6.  LaPiana FG, Penner R. Anaphylactoid reaction to intravenously admin-
istered fluorescein. Arch Ophthalmol. 1968;79:161–162.
  7.  Knudsen ST, Bek T, Poulsen PL, et al. Macular edema reflects 
  generalized vascular hyperpermeability in type 2 diabetic patients with 
retinopathy. Diabetes Care. 2002;25:2328–2334.
  8.  Early Treatment Diabetic Retinopathy Study Research Group. 
  Treatment techniques and clinical guidelines for photocoagulation of 
diabetic macular edema: Early Treatment Diabetic Retinopathy Study 
Report Number 2. Ophthalmology. 1987;94:761–774.
  9.  Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. 
Science. 1991;254:1178–1181.
  10.  Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic 
  retinopathy: A study using optical coherence tomography (OCT). 
Retina. 2002;22:759–767.
  11.  Sadda SR, Tan O, Walsh AC, et al. Automated detection of clini-
cally significant macular edema by grid scanning optical coherence 
  tomography. Ophthalmology. 2006;113:1187.e1–1187.e12.
  12.  Otani T, Kishi S. Correlation between optical coherence tomography 
and fluorescein angiography findings in diabetic macular edema. 
  Ophthalmology. 2007;114:104–107.
  13.  Soliman W, Sander B, Hasler PW, et al. Correlation between intrar-
retinal changes in diabetic macular oedema seen in fluorescein angiog-
raphy and optical coherence tomography. Acta Ophthalmol. 2008;86: 
34–39.
  14.  Bolz M, Ritter M, Schneider M, et al. A systematic correlation of 
angiography and high-resolution optical coherence tomography in 
diabetic macular edema. Ophthalmology. 2009;116:66–72.
  15.  Yeung L, Lima CV, Garcia P, et al. Correlation between spectral 
domain optical coherence tomography findings and fluorescein angiog-
raphy patterns in diabetic macular edema. Ophthalmology. 2009;116: 
1158–1167.